EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

Organization

Heard in 4 episodes across 1 show since Aug 2026

EyePoint Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of innovative ophthalmic products. The company leverages its proprietary drug delivery technologies, such as Durasert, to design sustained-release therapeutics for serious retinal diseases.

Learn more

Episodes

4
across 1 show

First heard

Aug 2026

Expert statements

2
1 negative

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20264
Sep 20260
Oct 20260

What experts have said about EyePoint Pharmaceuticals, Inc.

2 statements · 1 negative · 1 mixed

  1. Joe DeauxNegativeAug 17, 2026· Stock Movers

    EyePoint’s experimental eye-disease treatment failed its late-stage primary endpoint.

    “the drug developer said its experimental treatment for an eye disease failed to meet a primary goal in its late stage trial.”

    Listen at 3:15

    Open the episode · Closing Bell: Chip Stocks Rise, SpaceX Gains, EyePoint Sinks
  2. Joe DeauxMixedAug 17, 2026· Stock Movers

    EyePoint’s failed trial does not necessarily end its prospects.

    “that doesn't necessarily mean this is the end.”

    Listen at 3:46

    Open the episode · Closing Bell: Chip Stocks Rise, SpaceX Gains, EyePoint Sinks
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

4 episodes featuring EyePoint Pharmaceuticals, Inc., newest first

EyePoint Pharmaceuticals, Inc. · PodLume